Related Content

Web3 in the Pharmaceutical Industry

For decades, productivity and innovation in the pharmaceutical industry have declined. It has been slow to transform digitally and culturally. This research describes how executives can lead change by harnessing Web3 technologies. The payoffs will be greater internal rates of return on drug discovery and personalized medicine, and more efficient and secure clinical trials and supply chains among other significant benefits.

Read More

Cosmos and Polkadot for the Enterprise

This project explores one of the most critical implementation challenges of blockchain technologies: interoperability. Enterprise uses are reluctant to tokenize their assets or invest seriously in decentralized finance and digital asset management capabilities without assurances that they will be able to move these assets across blockchain platforms. What if chosen platforms fail? What if better platforms emerge? Some of the best minds in the space are addressing these issues head on with a range of innovative solutions. This project features two of them: Cosmos and Polkadot. It looks at their origins and ethos, architecture and core technology components (including the role of their native tokens ATOM and DOT), consensus and governance, and the applications already using them. Finally, the author reviews what enterprise decision-makers need to know as they weigh their options.

Read More
BRI Europe